Description
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Cas No. | 2446480-97-1 |
|---|---|
| Purity | ≥98% |
| Formula | C27H25F3N8O |
| Formula Wt. | 534.55 |
| IUPAC Name | 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine |
| Synonym | USP1-IN-1; KSQ4279 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Cadzow L, Brenneman J, Sullivan P, et al. Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers. Eur J Cancer. 2020 Oct 1;138(Supplement 2,S52).
Cadzow L, Tobin E, Sullivan P, et al. Abstract ND01: KSQ-4279: A first-in-class USP1 inhibitor for the treatment of cancers with homologous recombination deficiencies. Cancer Res. 2022;82(12_Supplement):ND01.
β-lactamase inhibitor.
Imidzoline derivative; MDM2 inhibitor.
Caffeic acid derivative.
Platelet substitute, peptide; GP IIb/IIIa activ...
STAT3 inhibitor.
Isoflavone found in Pueraria; 5-HT2C and GABA-A...
B-Raf and c-Raf inhibitor.
Lincosamide; ribosomal translocation and protei...
Histamine H2 inverse agonist.
Peptide found in crustaceans; PKA activator.
VEGFR, PDGFR, c-Kit inhibitor.
Peptide, vSrc-induced cytokine.
Mycotoxin produced by Aspergillus; actin polyme...
Alters membrane permeability, prevents transpor...
Non-depolarizing NMJ blocker; AChR antagonist.<...
Glutathione-sulforaphane conjugate, antioxidant...
Dihydropyrazine found in Ligusticum walliichi. ...
Imidazole; 14-α demethylase inhibitor.
May be useful against COVID-19
Carnitine derivative, involved in energy homeos...